Filter
389
Text search:
guidelines
for
pharmacovigilance
Featured
Recommendations
49
New Publications
115
Language
Document type
No document type
196
Guidelines
72
Studies & Reports
46
Strategic & Response Plan
32
Manuals
24
Training Material
7
Fact sheets
6
Situation Updates
3
Resource Platforms
1
Infographics
1
Online Courses
1
Countries / Regions
Kenya
23
Ghana
15
Uganda
15
India
14
Global
14
Western and Central Europe
13
Nigeria
12
Namibia
12
South Africa
11
Ethiopia
10
Eastern Europe
10
Nepal
9
Zambia
8
Rwanda
8
Sierra Leone
7
Tanzania
7
Malawi
7
Cambodia
5
South–East Asia Region
5
Latin America and the Carribbean
5
Liberia
4
Senegal
4
Bangladesh
4
Zimbabwe
3
Botswana
3
Lesotho
3
West and Central Africa
3
Russia
3
Congo, Democratic Republic of
2
Haiti
2
Philippines
2
Indonesia
2
Mozambique
2
Sudan
2
Eswatini/ Swaziland
2
Brazil
2
Myanmar / Burma
2
East and Southern Africa
2
Middle East and North Africa
2
Eastern Europe and Central Asia
2
Asia
2
Africa
2
Guinea
1
Côte d’Ivoire / Ivory Coast
1
Morocco
1
Cameroon
1
Togo
1
Pakistan
1
Jordan
1
Afghanistan
1
Lebanon
1
Syria
1
Thailand
1
Gambia
1
Benin
1
Argentina
1
Burundi
1
Ukraine
1
Libya
1
Sri Lanka
1
Yemen
1
Western Pacific Region
1
Paraguay
1
Bhutan
1
Southern Africa
1
Laos
1
Georgia
1
Vietnam
1
Maldives
1
Authors & Publishers
Publication Years
Category
Countries
197
Clinical Guidelines
49
Public Health
9
Pharmacy & Technologies
8
Capacity Building
6
Women & Child Health
6
Key Resources
6
Toolboxes
TB
47
Pharmacy
44
AMR
32
Malaria
31
HIV
22
COVID-19
21
NTDs
17
NCDs
5
Rapid Response
3
Refugee
2
Caregiver
2
Planetary Health
2
Ebola & Marburg
1
Cholera
1
Polio
1
Specific Hazards
1
2.0 Rapid Response
1
Against this background of nearly 20 years of experience of research, development and
improvement in patient safety, the role of incident and adverse event reporting, as well as the
benefits that derive from it, is still a work in progress.This document has two main purposes:
• to provide an up
...
El grupo de Farmacovigilancia de la red Panamericana para la Armonización Farmacéutica (PARF) de la Organización Panamericana de la Salud (OPS), ha desarrollado este documento desde la visión OPS/OMS, considerando que la farmacovigilancia es un componente esencial de los programas de salud públ
...
A review of available evidence (2016).
28-29 June 2016; Geneva, Switzerland
The END TB strategy.
his Framework begins with a desired future scenario and considers actions and interventions necessary to get there. It advocates for holistic view to address tuberculosis. The Framework revisits challenges and actions in four layers: TB specific; ch
...
The National Malaria Elimination Strategic Plan (NMESP) 2024–2028 of Ghana outlines the country’s roadmap to shift from malaria control to elimination. Despite major progress—like reducing malaria deaths from nearly 2,800 in 2012 to 151 in 2022—malaria remains a major public health challenge
...
The National Strategic Plan on Malaria Prevention and Elimination Period 2021 – 2025 seeks to build on the previous national successes of the National Institute of Malariology, Parasitology, and Entomology (NIMPE) while addressing current challenges to reduce the overall burden of malaria in the S
...
Apart from implementation of TB infection Prevention and Control measures, treatment of those with active TB of the lungs is key in preventing the spread of the TB bacilli. The Public Health Act CAP 242, section 17 classify TB as notifiable infectious disease and under section 26 as part of preventi
...
Reach the Unreached - FIND, TREAT, CURE TB, SAVE LIVES
The Ghana National Malaria Strategic Plan 2021–2025 aims to reduce malaria mortality by 90% and malaria cases by 50% (using 2019 as baseline) and to achieve pre-elimination in at least six districts by 2025. The plan focuses on scaling up prevention measures like distributing insecticide-treated n
...
National Tuberculosis and Leprosy Conrol Programme
TB in India 2017
recommended
Revised National TB Control Programme. Annual Status Report
